In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues

(2015) Andrea Antinori et al.   AIDS

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients

(2015) Qing Ma et al.   JOURNAL OF NEUROVIROLOGY

Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells

(2014) Nadezda Apostolova et al.   JOURNAL OF INFECTIOUS DISEASES

Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system

(2014) Cagla Akay et al.   JOURNAL OF NEUROVIROLOGY

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study

(2014) Roberta Gagliardini et al.   Journal of the International AIDS Society

Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism

(2013) Lucia Lisi et al.   JOURNAL OF NEUROIMMUNOLOGY

Peripheral neuropathy in ART-experienced patients: prevalence and risk factors

(2013) Huichao Chen et al.   JOURNAL OF NEUROVIROLOGY

Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II

(2013) Tiziana Latronico et al.   PLoS One

Impact of Manganese Neurotoxicity on MMP-9 Production and Superoxide Dismutase Activity in Rat Primary Astrocytes. Effect of Resveratrol and Therapeutical Implications for the Treatment of CNS Diseases

(2013) Tiziana Latronico et al.   TOXICOLOGICAL SCIENCES

Antiretroviral neurotoxicity

(2012) Kevin Robertson et al.   JOURNAL OF NEUROVIROLOGY

Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients

(2011) Grazia Maria Liuzzi et al.   NEUROCHEMICAL RESEARCH

In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection

(2011) Pasqua Gramegna et al.   PLoS One

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

(2010) K. R. Robertson et al.   NEUROLOGY

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Pathogenesis of HIV in the Central Nervous System

(2010) Victor Valcour et al.   Current HIV/AIDS Reports

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients

(2009) Aylin Yilmaz et al.   AIDS

Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected Individuals

(2009) Aylin Yilmaz et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection

(2009) Aylin Yilmaz et al.   PLoS One